Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oxigene and Techniclone join forces to develop new-generation anticancer agents

March 14, 2000

Distamycin used as lead at P&U to design new alkylating agents

March 13, 2000

AEterna cleared to commence phase III trial of AE-941 for treatment of kidney cancer

March 13, 2000

Malignant melanoma antisense compound enters pivotal trials

March 13, 2000

Patent covers charged tamoxifen derivatives for cancer therapy

March 13, 2000

Novel dinoflagellate-produced macrolide is cytotoxic to leukemia cells

March 10, 2000

Novel antitumor antibiotic identified from Streptomyces strain

March 10, 2000

Immune Response assesses brain tumor vaccine in phase I trial

March 10, 2000

The FDA approves Viadur for once-yearly palliative treatment of advanced prostate cancer

March 10, 2000

FDA grants fast track status to BNP-7787 for treating paclitaxel-induced neurotoxicity

March 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...